Glenmark unveils generic version of Gilenya Capsules in US Ruchika Sharma2 Nov 2022 9:00 AM GMTMumbai: Drugmaker Glenmark Pharmaceuticals Inc., USA, has recently announced the launch of Fingolimod Capsules, 0.5 mg in the US. The...
CDSCO panel tells Glenmark to submit complete clinical trial report on antidiabetic FDC Drug Dr. Nandita Mohan24 Sep 2022 12:13 PM GMTIn response to drug major Glenmark proposal to manufacture and market the antidiabetic fixed dose combination Lobeglitazone Sulphate 0.5/0.5mg plus...
Health Bulletin 24/September/2022 Dr. Nandita Mohan24 Sep 2022 11:47 AM GMTHere are the top health news for the day:Submit complete CT Report: CDSCO tells Glenmark on antidiabetic FDC drugIn response to drug major Glenmark...
Glenmark Pharma North Carolina facility gets USFDA OAI status Ruchika Sharma25 Aug 2022 6:25 AM GMTMumbai: Glenmark Pharmaceuticals Limited has recently announced that the company has received Official Action Indicated (OAI) status from the US Food...
Sun Pharma, Glenmark recall products in US Rahul Verma25 July 2022 11:58 AM GMTLeading drug makers Sun Pharma and Glenmark are recalling products in the US, the world's largest market for medicines, due to lapses in the...
Glenmark, Sun Pharma recall products in US over manufacturing issues Ruchika Sharma25 July 2022 6:03 AM GMTNew Delhi: Leading drug makers Sun Pharma and Glenmark are recalling products in the US, the world's largest market for medicines, due to lapses in...
Glenmark Pharma launches Sitagliptin and its FDCs for Type 2 diabetes in India Ruchika Sharma7 July 2022 9:58 AM GMTThe medicines will be available under the brand name SITAZIT, SITAZIT- M, SITAZIT- M ER and SITAZIT D.
Glenmark gets one USFDA observation for Aurangabad facility Ruchika Sharma2 July 2022 10:59 AM GMTNew Delhi: Glenmark Pharmaceuticals Limited has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with...
Glenmark gets CDSCO Panel nod to study antidiabetic FDC containing Dapagliflozin, Sitagliptin, Metformin Susmita Roy27 Jun 2022 12:45 PM GMTNew Delhi: Granting the waiver of bioequivalence study, the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO)...
Glenmark receives 6 USFDA observations for Baddi facility Roshni Dhar24 Jun 2022 12:30 PM GMTDrugmaker, Glenmark Pharmaceuticals Ltd, has recently announced that the US Food and Drug Administration (USFDA) has issued Form 483 with six...
Health Bulletin 24/June/2022 Roshni Dhar24 Jun 2022 11:50 AM GMTHere are the top health stories for the day:NEET 2022 not postponed Breaking the hearts of all the NEET UG 2022 aspirants, who have...
Glenmark Baddi facility gets 6 USFDA observations Ruchika Sharma23 Jun 2022 8:00 AM GMTNew Delhi: Drugmaker, Glenmark Pharmaceuticals Ltd, has recently announced that the US Food and Drug Administration (USFDA) has issued Form...
